Re: [procaare] New AIDS Study Shows Efficacy of Cheaper Drug

[Ifedayo Adetifa <procaare@healthnet.org>]

Re: [procaare] New AIDS Study Shows Efficacy of Cheaper Drug
-Ifedayo Adetifa, Nigeria
***************************

Dear Colleagues,

This is very good news for those of us managing persons living with HIV/AIDS in resource
limited settings as exist in my country Nigeria.

My review of existing literature had come up with Sustiva being the only NNRTI with the
efficacy of PI-based regime's and I had felt that our population of patients with assumed
very high viral loads were being given sub optimal therapy using a Dual Nucleoside
backbone and Viramune.

regards,

Ifedayo Adetifa MD
Nigeria
Email:ifedayo_tiffy@yahoo.com

--
To send a message to ProCAARE, write to: procaare@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe procaare OR unsubscribe procaare
To contact a person, send a message to: procaare-help@usa.healthnet.org
Information and archives: http://www.procaare.org

The views presented in ProCAARE do not necessarily reflect the opinions of
SATELLIFE  (http://www.healthnet.org), the Harvard AIDS Institute
(http://aids.harvard.edu), or Health & Development Networks
(http://www.hdnet.org), unless otherwise stated. The reader assumes all
responsibilities in using information posted or archived by ProCAARE.
Reproduction is welcomed, provided ProCAARE and procaare@usa.healthnet.org
are quoted, and SATELLIFE is informed of usage.